[Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59].
Marcin Dominiak(Uniwersytecki Szpital Kliniczny w Opolu)
PubMed
June 1, 2008
Cited by 581
Abstract
Related Papers
No related papers found
Powered by citation graph analysis